These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10594354)

  • 41. Purification of monoclonal antibodies from tissue culture medium depleted of IgG.
    Darby CR; Hamano K; Wood KJ
    J Immunol Methods; 1993 Feb; 159(1-2):125-9. PubMed ID: 8445245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of Monoclonal Antibodies in Serum-free Media.
    Manna L; Di Febo T; Armillotta G; Luciani M; Ciarelli A; Salini R; Di Ventura M
    Monoclon Antib Immunodiagn Immunother; 2015 Aug; 34(4):278-88. PubMed ID: 26301933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of a murine monoclonal antibody with anti-HIV-1 neutralizing properties.
    Hinkula J; Gilljam G; Wahren B
    J Clin Lab Anal; 1991; 5(6):399-405. PubMed ID: 1774604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bovine serum albumin affects N-glycoforms of murine IgG monoclonal antibody purified from hybridoma supernatants.
    Zhou J; Gao H; Xie W; Li Y
    Appl Microbiol Biotechnol; 2020 Feb; 104(4):1583-1594. PubMed ID: 31915902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A purification strategy for the production of clinical grade monoclonal antibodies.
    Jiskoot W; Gebbinck JW; van Hertrooij JJ; van der Velden-de Groot T; Crommelin DJ; Beuvery EC
    Dev Biol Stand; 1990; 71():73-8. PubMed ID: 2401388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered antigenicity of human monoclonal antibodies derived from human-mouse heterohybridomas.
    Kan-Mitchell J; Andrews KL; Gallardo D; Mitchell MS
    Hybridoma; 1987 Apr; 6(2):161-72. PubMed ID: 3552958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new serum-free medium for monoclonal antibody production.
    Wolfe RA; Braatz JA; Miller DA; Heifetz AH
    Biotechniques; 1988 Jan; 6(1):62-7. PubMed ID: 3273394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum-free hybridoma culture: ethical, scientific and safety considerations.
    Even MS; Sandusky CB; Barnard ND
    Trends Biotechnol; 2006 Mar; 24(3):105-8. PubMed ID: 16427150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large-scale production of monoclonal antibodies in defined serum-free media in airlift bioreactors.
    Petrossian A; Cortessis GP
    Biotechniques; 1990 Apr; 8(4):414-22. PubMed ID: 2340179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
    Salgar SK; Paape MJ; Alston-Mills B
    Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation and characterization of monoclonal antibodies against prostate-specific antigen.
    Karuppaiya A; Cheah SH; Mohd S; Kamal WH; Zulkifli MH
    Hybridoma (Larchmt); 2009 Apr; 28(2):133-7. PubMed ID: 19249990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of small to moderate scale in vitro monoclonal antibody production via the use of the i-MAb gas-permeable bag system.
    Lipski LA; Witzleb MP; Reddington GM; Reddington JJ
    Res Immunol; 1998; 149(6):547-52. PubMed ID: 9835416
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of three-dimensional culturing in a fibrous matrix on cell cycle, apoptosis, and MAb production by hybridoma cells.
    Luo J; Yang ST
    Biotechnol Prog; 2004; 20(1):306-15. PubMed ID: 14763857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell growth and monoclonal antibody production in the presence of antigen and serum.
    Dandulakis G; Herr JC; Kirwan DJ
    Biotechnol Prog; 1995; 11(5):518-24. PubMed ID: 8546836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of Monoclonal Antibody That Recognizes Zika Virus and Other Flaviviruses in Serum-Free Conditions.
    Conte FP; Martins RS; Cajaraville ACDRA; Nascimento HJ; Jurgilas PB; de Lima SMB; Missailidis S; Arissawa M
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):264-271. PubMed ID: 29211630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of alpha-ketoglutarate on monoclonal antibody production of hybridoma cell lines in serum-free and serum-containing medium.
    Nilsang S; Kumar A; Rakshit SK
    Appl Biochem Biotechnol; 2008 Dec; 151(2-3):489-501. PubMed ID: 18696264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3.
    van Ravenswaay Claasen HH; van de Griend RJ; Mezzanzanica D; Bolhuis RL; Warnaar SO; Fleuren GJ
    Int J Cancer; 1993 Aug; 55(1):128-36. PubMed ID: 8344744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hybridoma growth and monoclonal antibody production in a dialysis perfusion system.
    Amos B; al-Rubeai M; Emery AN
    Enzyme Microb Technol; 1994 Aug; 16(8):688-95. PubMed ID: 7765078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.